CapsCanada
Specialty Enzymes

Click Here for the Latest Episode of the Vitamin Professor Podcast Hosted by Gene Bruno

FD&C Act


FDA Holds Public Meeting Exploring Scope of Dietary Supplement Ingredients

by Shari Barbanel | April 8, 2026

On March 27, the U.S. Food and Drug Administration (FDA) hosted a public meeting on the scope of dietary supplement ingredients. The event was held in-person from 9 a.m. to 3 p.m. EST at Wiley Auditorium, 5001 Campus Dr. in College Park, MD and virtually. FDA’s Office of Dietary Supplement Programs (ODSP) invited stakeholders to participate in ...

FDA Releases New Dietary Ingredient Final Guidance, Associations Respond

by Shari Barbanel | March 6, 2024

On March 5, the U.S. Food and Drug Administration (FDA) announced the availability of a final guidance for industry titled “Dietary Supplements: New Dietary Ingredient Notification Procedures and Timeframes: Guidance for Industry.” According to the FDA, the guidance is intended to help manufacturers and distributors of new dietary ingredients (NDIs) and dietary supplements prepare and ...

FDA Warns Selling of Topical CBD Products Violates FD&C Act

by Shari Barbanel | March 29, 2021

On March 22, the U.S. Food and Drug Administration (FDA) stated that it has issued warning letters to two companies for selling topical pain relief products labeled as containing cannabidiol (CBD) in ways that violate the Federal Food, Drug and Cosmetic Act (FD&C Act). Specifically, the warning letters addressed the illegal marketing of unapproved drugs ...

FDA Issues CBD Warning Letters

by Shari Barbanel | December 4, 2019

The U.S. Food and Drug Administration (FDA) recently issued warning letters to 15 companies for, according the agency, illegally selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). The FDA also published a revised Consumer Update detailing safety concerns about CBD products more broadly. The agency stated, based ...

AHPA Submits Vinpocetine Comments to FDA

by Shari Barbanel | November 21, 2016

The American Herbal Products Association (AHPA) recommends the Secretary of Health and Human Services (HHS) consider initiating rulemaking to declare vinpocetine to be lawful dietary ingredient in comments submitted to the U.S. Food and Drug Administration (FDA). AHPA also strongly encouraged FDA to clarify that if vinpocetine is either found to be currently in the ...

Don't Miss Out!

Sign up for Nutrition Industry Executive Digital Newsletter
Digital Newsletter
Subscribe to Nutrition Industry Executive Magazine
Nutrition Industry Executive Magazine

Industry Professionals
Stay Informed!

Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.

Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.

Featured Listings:


CapsCanada

Subscribe To Our Newsletter

Stay Informed! Breaking news, industry trends featured topics, and more.

Subscribe to our newsletter today!